No Data
No Data
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
LAVA Therapeutics N.V. (NASDAQ: LVTX) today announced that Stephen Hurly, President and Chief Executive Officer of LAVA Therapeutics, will participate in a fireside chat at the Citizens JMP Life Sciences Conference.
Analysts Offer Insights on Healthcare Companies: LAVA Therapeutics (LVTX), Acumen Pharmaceuticals (ABOS) and Advanced Medical Solutions (GB:AMS)
Buy Rating Affirmed for LAVA Therapeutics Amid Promising T-Cell Cancer Therapy Trials and Strong Financials
LAVA Therapeutics: A Strong Buy on Robust Financials and Promising Oncology Pipeline Advancements
LAVA Therapeutics GAAP EPS of -$0.24 Beats by $0.18
LAVA Therapeutics Announces Progress and Stability
No Data